Original paper
Prognostic and predictive value of the Immunoscore in stage III colon cancer patients treated with oxaliplatin in the prospective IDEA France PRODIGE-GERCOR cohort study
Abstract
•This study provides evidence for the feasibility and reproducibility of the Immunoscore (IS) test.•The IS prognostic value for disease-free survival (DFS) is demonstrated in stage III patients treated with oxaliplatin-based chemotherapy.•A predictive value of the IS (Int + High) for DFS benefit of longer duration of mFOLFOX6 treatment is observed.•Patients with low- and high-risk stage having IS Int + High significantly benefit from 6 months'...
Paper Details
Title
Prognostic and predictive value of the Immunoscore in stage III colon cancer patients treated with oxaliplatin in the prospective IDEA France PRODIGE-GERCOR cohort study
Published Date
Jul 1, 2020
Journal
Volume
31
Issue
7
Pages
921 - 929
Citation AnalysisPro
You’ll need to upgrade your plan to Pro
Looking to understand the true influence of a researcher’s work across journals & affiliations?
- Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
- Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.
Notes
History